Connect with us
49,925 – The number of comments received by the Drug Enforcement Agency regarding rescheduling cannabis The Drug Enforcement Agency was flooded with submissions in the final...
Rescheduling marijuana from Schedule I to Schedule III could catalyze a surge of new job openings in the industry by 2030, according to a report submitted...
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) reported total revenue for its fiscal third quarter, which ended May 31, increased 27.6% to C$26.2 million versus C$20.6...
It’s been a minute since the market has seen a medical cannabis company go public via a SPAC. Phytanix Bio, a pharmaceutical company dedicated to the...
While the impact of rescheduling cannabis to Schedule III has taken many turns, one area that hasn’t been dissected is the move’s effect on accessories or...
36,919 is the amount of comments that the DEA received on rescheduling. Number of the week: 49,925. These are the amount of comments that the Drug...
The Daily Hit is a recap of the top financial news stories for Monday, July 22, 2024. On the Site The DEA marijuana rescheduling comment period...
Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company...
Monday marks the last date on which the U.S. Drug Enforcement Administration was accepting comments from members of the public on a marijuana rescheduling proposal, which...
The U.S. Food and Drug Administration has intensified its warning against Diamond Shruumz-brand products as reports of severe illnesses linked to the company’s edibles continue to...
